JO
NRXP icon

John Overdeck’s NRX Pharmaceuticals NRXP Stock Holding History

John Overdeck’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
+26,429
New +$87.3K ﹤0.01% 4878
2026
Q1 		– Sell
-17,436
Closed -$47.3K – 4816
2025
Q4 		$47.3K Sell
17,436
-34,896
-67% -$93.7K ﹤0.01% 3943
2025
Q3 		$173K Buy
52,332
+20,880
+66% +$59.8K ﹤0.01% 3399
2025
Q2 		$103K Buy
31,452
+1,306
+4% +$3.27K ﹤0.01% 2994
2025
Q1 		$61.8K Buy
+30,146
New +$84.9K ﹤0.01% 3026
2022
Q3 		– Sell
-4,145
Closed -$25K – 2703
2022
Q2 		$25K Buy
+4,145
New +$54.4K ﹤0.01% 2389

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

John Overdeck's NRXP Position: Q2 2026 in Review

John Overdeck opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 26,429 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #4878 among its holdings. This is a return to the name: John Overdeck previously reported a position in NRXP as recently as Q4 2025.

John Overdeck first reported a position in NRXP in Q2 2022 and has held it in 6 quarters since. The position peaked at $173K in Q3 2025. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • John Overdeck held 26,429 shares of NRX Pharmaceuticals worth $108K as of Q2 2026.
  • NRX Pharmaceuticals was a new John Overdeck position in Q2 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4878 holding.
  • John Overdeck first reported a position in NRX Pharmaceuticals in Q2 2022 and has held it in 6 quarters since.
  • John Overdeck's NRX Pharmaceuticals position peaked at $173K in Q3 2025.
  • 47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.